OraSure Technologies | OSUR - Ebitda

Aktienkurs
3.08
Täglich Wechseln
0.13 4.41%
Monatlich
9.22%
Jährlich
-15.85%
Q1 Prognose
2.86




Ebitda Veränderung Datum
Agilent USD 540M 74M 2025-09
AngioDynamics USD 5.94M 3.78M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio Techne USD 103.42M 7.47M 2025-12
Bio-Rad Laboratories USD -374.6M 841.8M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Danaher USD 2.13B 252M 2025-12
Dentsply International USD 135M 32M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Exact Sciences USD 135.42M 2.8M 2025-09
Hologic USD 330.4M 16.6M 2025-12
Illumina USD 332M 12M 2025-09
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 919.7M 21M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Mesa Laboratories USD 9.58M 1.47M 2024-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Quidel USD 153.3M 23.8M 2025-12
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
STAAR Surgical USD -159K 34.78M 2025-12
Thermo Fisher Scientific USD 3.17B 335M 2025-12
Trinity Biotech USD -9.6M 7.64M 2024-12
Waters USD 380.97M 85.83M 2025-12